Is the blood-brain barrier differentially affected by different variants of migraine?
This scientific commentary refers to 'Ictal lack of binding to brain parenchyma suggests integrity of the bloodbrain barrier for 11 C-dihydroergotamine during glyceryl trinitrate-induced migraine', by Schankin et al. (doi:10.1093/brain/aww096) .
In this issue of Brain, Schankin and co-workers study the permeability of the blood-brain barrier in six migraineurs and six control subjects at rest and during acute glyceryl trinitrate-induced migraine attacks without aura, using PET with the novel radioligand 11 C-dihydroergotamine ( 11 C-DHE) (Schankin et al., 2016) . This radioligand is chemically identical to pharmacologically active DHE, a potent drug for the treatment of migraine headache. While 11 C-DHE was seen to bind to structures that lack a blood-brain barrier such as the choroid plexus and pituitary gland, no binding was observed in the brain parenchyma either at rest or during attacks. Specifically, no binding occurred in the hippocampus, which shows the highest density of the highest affinity DHE receptors, and the raphe nuclei, a postulated brainstem site of action during migraine. The study thus suggests that the bloodbrain barrier remains closed during attacks of migraine headache. This may guide the future development of anti-migraine drugs because it indicates that targets outside of the brain parenchyma are involved to such an extent in the generation and maintenance of migraine headache that pharmacological modulation of these targets alone may antagonize the headache. In other words, it does not seem essential for anti-migraine drugs to directly interfere with central pain centres. The advantages are obvious in that CNS side effects could potentially be avoided.
Moreover, the study by Schankin et al. raises an interesting pathophysiological question. Migraine aura is assumed to be one of the clinical correlates of spreading depolarization. The term spreading depolarization describes waves of abrupt, sustained breakdown of neuronal transmembrane ion gradients and depolarization en masse in the brain. The same phenomenon also occurs in conditions other than migraine such as stroke and traumatic brain injury (Dreier and Reiffurth, 2015) . In normally functioning tissue, spreading depolarization induces spreading depression of spontaneous activity because the sustained depolarization exceeds the inactivation threshold for action potential-generating channels. It is assumed that the patient perceives such spreading depression of activity as migraine aura if the spreading depolarization runs through perceptual and eloquent brain regions. In migraineurs, spreading depolarization may then trigger headache, which typically follows the aura.
While the present study found no evidence for opening of the blood-brain barrier in migraine without aura, previous neuroimaging studies of patients with severe variants of migraine with aura have obtained evidence of blood-brain barrier opening (Dreier et al., 2005; Cha et al., 2007) . Accordingly, spreading depolarization was found to induce opening of the blood-brain barrier via matrix metalloproteinase 9 (MMP9) activation in rodents (Gursoy-Ozdemir et al., 2004) . Does this imply that one could differentiate between migraine without and with aura through neuroimaging studies of the blood-brain barrier?
First, it must be stated that glyceryl trinitrate, the trigger of migraine headache applied in the present study and an inducer of delayed dural inflammation in animal models of migraine headache (Reuter et al., 2001) , is in fact unlikely to have caused the headache via induction of a silent spreading depolarization (Woods et al., 1994) . This is because glyceryl trinitrate is converted to nitric oxide (NO), and yet reduced nitric oxide enhanced susceptibility to spreading depolarization in vivo and in vitro in rodents (Petzold et al., 2008) . Likewise, nitric oxide reduced the propagation velocity of spreading depolarization in the chicken retina (Ulmer et al., 1995) . In other words, the migraine attacks observed in the study by Schankin and co-workers are unlikely to have been associated with spreading depolarization. On the other hand, the ability of glyceryl trinitrate to trigger migraine headache supports the notion that spreading depolarization triggers headache in migraineurs with aura because spreading depolarization leads to a large increase in nitric oxide in animals.
So, the question arises as to whether spreading depolarization always leads to opening of the blood-brain barrier. In a rodent model, Gursoy-Ö zdemir and co-workers (2004) investigated the effect of three pinprick-induced spreading depolarizations on the blood-brain barrier after removing large parts of the calvarium bilaterally and opening the dura mater. Such procedures inevitably activate astrocytes and microglial cells throughout both hemispheres, which implies that the three spreading depolarizations met a preactivated brain with some degree of inflammation. This is important to note because it is increasingly recognized that spreading depolarizations can vary dramatically depending on the local tissue conditions (Dreier and Reiffurth, 2015) . Notably, the full spreading depolarization continuum may be observed along a single wave, which spreads across the tissue. Mechanistic variations within the spreading depolarization continuum include, for example, the nature of the local initiation, the pharmacological profile, neurovascular responses and even whether or not the wave is locally reversible. Hence it could well be that spreading depolarization opens the blood-brain barrier under one set of tissue conditions but not another. Surgical procedures less invasive than those of Gursoy-Ö zdemir et al. are needed to render studies more relevant to regular migraine attacks with aura. The importance of the Gursoy-Ö zdemir et al. (2004) work lies in the fundamental observation that spreading depolarization can cause opening of the blood-brain barrier under certain conditions, consistent with the abovementioned case studies in patients with familial hemiplegic migraine (Dreier et al., 2005; Cha et al., 2007) . However, universal validity of this link cannot be derived from these findings.
In conclusion, future studies should address the question of whether blood-brain barrier opening is observed during or after unprovoked attacks of migraine aura. Such studies will face well known logistical challenges and, in the event that no opening of the blood-brain barrier is detected, will need to overcome the publication bias against negative results in a similar fashion to the study by Schankin et al. Unfortunately, in contrast to glyceryl trinitrate-triggered migraine headache, there seems to be no suitable trigger for migraine aura. In previous cerebral blood flow studies using 133 Xe, the procedure of catheterizing and injecting the carotid artery provoked aura in more than 50% of migraineurs (Lassen and Friberg, 1991) . However, such procedures carry a small risk of stroke and therefore cannot be recommended.
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